You can buy or sell Radius Health and other stocks, options, ETFs, and crypto commission-free!
Radius Health, Inc. Common Stock, also called Radius Health, is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. Read More The company's lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes abaloparatide transdermal patch for potential use in osteoporosis and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Waltham, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues
Radius Health, Inc. RDUS reported mixed results for the first quarter of 2019, wherein loss was narrower than expected but sales missed estimates. The company incurred a loss of 94 cents per share in the quarter, narrower than the Zacks Consensus Estimate of a loss of 95 cents and the year-ago loss of $1.11. The year-over-year improvement was backed by an increase in revenues. The company reported Tymlos’ sales of $29.8 million, missing the Zacks Consensus Estimate of $34.8 million. Quarter in Detail We...
Yahoo FinanceMay 9
Here’s What Hedge Funds Think About Radius Health Inc (RDUS)
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won't accept your savings unless you commit at least $5 million) by pinpointing winning small-cap stocks.
Seeking AlphaMay 8
Radius Health, Inc. CEO Jesper Høiland on Q1 2019 Results - Earnings Call Transcript
Radius Health, Inc. (NASDAQ:RDUS) Q1 2019 Earnings Conference Call May 8, 2019 8:00 AM ET Company Participants Elhan Webb - Head, IR & External Communications Jesper Høiland - President, CEO & Director Joseph Kelly - SVP, Sales & Marketing Charles Morris - Chief Medical Officer Jose Carmona - CFO, SVP & Treasurer Bruce Mitlak - Head, Clinical Development for Osteoporosis Conference Call Participants Jessica Fye - JPMorgan Chase & Co. Alec Stranahan - Bank of America Merrill Lynch Bradley Canino -...
Expected Aug 8, Pre-Market